A novel model for Ki67 assessment in breast cancer.

Summary, in English

Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.

• Author: Quinci Romero; Pär-Ola Bendahl; Mårten Fernö; Dorthe Grabau; Signe Borgquist
• Department/s: Breastcancer-genetics; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Tumor microenvironment
• Publishing year: 2014
• Language: English
• Publication/Series: Diagnostic Pathology
• Volume: 9
• Issue: 1
• Full text: - 1 MB; Download statistics
• Links: http://www.ncbi.nlm.nih.gov/pubmed/24934660?dopt=Abstract; http://dx.doi.org/10.1186/1746-1596-9-118
• Document type: Journal article
• Publisher: BioMed Central (BMC)
• Topic: Cancer and Oncology
• Status: Published
• ISBN/ISSN/Other: ISSN: 1746-1596